| abstract |
The present invention relates to antibody-like binding proteins that specifically bind to CD3 and CD123. The invention also relates to a pharmaceutical composition comprising the antibody-like binding protein and the use of the pharmaceutical composition and the antibody-like binding protein for treating cancer. The invention further relates to an isolated nucleic acid, a vector and a host cell comprising a sequence encoding said antibody-like binding protein. |